BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is being increasingly used as a bridge to lung transplantation. Small, single-institution series have described increased success using ECMO in spontaneously breathing patients compared with patients on ECMO with mechanical ventilation, but this strategy has not been evaluated on a large scale. METHODS: Using the United Network for Organ Sharing database, all adult patients undergoing isolated lung transplantation from May 2005 through September 2013 were identified. Patients were categorized by their type of pretransplant support: no support, ECMO only, invasive mechanical ventilation (iMV) only, and ECMO + iMV. Kaplan-Meier survival analysis with log-rank testing was performed to compare survival based on type of preoperative support. A Cox regression model was used to determine whether type of preoperative support was independently associated with survival, using previously established predictors of survival as covariates. RESULTS: Approximately 12,403 primary adult pulmonary transplantations were included in this analysis. Sixty-five patients (0.52%) were on ECMO only, 612 (4.93%) required only iMV, 119 (0.96%) were on ECMO + iMV, and the remaining 11,607 (94.6%) required no invasive support before transplantation. One-year survival was decreased in all patients requiring support, regardless of type. However, mid-term survival was similar between patients on ECMO alone and those not on support but significantly worse with patients requiring iMV only or ECMO + iMV. In multivariable analysis, ECMO + iMV and iMV alone were independently associated with decreased survival compared with nonsupport patients, whereas ECMO alone was not significant. CONCLUSIONS: In patients with worsening pulmonary disease awaiting lung transplantation, those supported via ECMO with spontaneous breathing demonstrated improved survival compared with other bridging strategies.
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is being increasingly used as a bridge to lung transplantation. Small, single-institution series have described increased success using ECMO in spontaneously breathing patients compared with patients on ECMO with mechanical ventilation, but this strategy has not been evaluated on a large scale. METHODS: Using the United Network for Organ Sharing database, all adult patients undergoing isolated lung transplantation from May 2005 through September 2013 were identified. Patients were categorized by their type of pretransplant support: no support, ECMO only, invasive mechanical ventilation (iMV) only, and ECMO + iMV. Kaplan-Meier survival analysis with log-rank testing was performed to compare survival based on type of preoperative support. A Cox regression model was used to determine whether type of preoperative support was independently associated with survival, using previously established predictors of survival as covariates. RESULTS: Approximately 12,403 primary adult pulmonary transplantations were included in this analysis. Sixty-five patients (0.52%) were on ECMO only, 612 (4.93%) required only iMV, 119 (0.96%) were on ECMO + iMV, and the remaining 11,607 (94.6%) required no invasive support before transplantation. One-year survival was decreased in all patients requiring support, regardless of type. However, mid-term survival was similar between patients on ECMO alone and those not on support but significantly worse with patients requiring iMV only or ECMO + iMV. In multivariable analysis, ECMO + iMV and iMV alone were independently associated with decreased survival compared with nonsupport patients, whereas ECMO alone was not significant. CONCLUSIONS: In patients with worsening pulmonary disease awaiting lung transplantation, those supported via ECMO with spontaneous breathing demonstrated improved survival compared with other bridging strategies.
Authors: Kyle J Rehder; David A Turner; Matthew G Hartwig; W Lee Williford; Desiree Bonadonna; Richard J Walczak; R Duane Davis; David Zaas; Ira M Cheifetz Journal: Respir Care Date: 2012-12-04 Impact factor: 2.258
Authors: D C Neujahr; S D Perez; A Mohammed; O Ulukpo; E C Lawrence; F Fernandez; A Pickens; S D Force; M Song; C P Larsen; A D Kirk Journal: Am J Transplant Date: 2011-12-07 Impact factor: 8.086
Authors: Awori J Hayanga; Jonathan Aboagye; Stephen Esper; Norihisa Shigemura; Christian A Bermudez; Jonathan D'Cunha; Jay K Bhama Journal: J Thorac Cardiovasc Surg Date: 2014-09-17 Impact factor: 5.209
Authors: Stefan Fischer; Desmond Bohn; Peter Rycus; Andrew F Pierre; Marc de Perrot; Thomas K Waddell; Shaf Keshavjee Journal: J Heart Lung Transplant Date: 2007-05 Impact factor: 10.247
Authors: Jeffrey Javidfar; Daniel Brodie; Alex Iribarne; Julissa Jurado; Matthew Lavelle; Keith Brenner; Selim Arcasoy; Joshua Sonett; Matthew Bacchetta Journal: J Thorac Cardiovasc Surg Date: 2012-07-15 Impact factor: 5.209
Authors: Jens Gottlieb; Jacqueline Smits; Rene Schramm; Frank Langer; Roland Buhl; Christian Witt; Martin Strueber; Hermann Reichenspurner Journal: Dtsch Arztebl Int Date: 2017-03-17 Impact factor: 5.594
Authors: Nicholas A Kolaitis; Allison Soong; Pavan Shrestha; Hanjing Zhuo; John Neuhaus; Patti P Katz; John R Greenland; Jeffrey Golden; Lorriana E Leard; Rupal J Shah; Steven R Hays; Jasleen Kukreja; Mary Ellen Kleinhenz; Paul D Blanc; Jonathan P Singer Journal: J Thorac Cardiovasc Surg Date: 2018-02-22 Impact factor: 5.209
Authors: Ryan A Orizondo; Katelin S Omecinski; Alexandra G May; Vishaal Dhamotharan; Brian J Frankowski; Greg W Burgreen; Sang-Ho Ye; Ergin Kocyildirim; Pablo G Sanchez; Jonathan D'Cunha; William R Wagner; William J Federspiel Journal: Transplantation Date: 2021-05-01 Impact factor: 5.385
Authors: Jonathan E Millar; Jonathon P Fanning; Charles I McDonald; Daniel F McAuley; John F Fraser Journal: Crit Care Date: 2016-11-28 Impact factor: 9.097